Epilepsy Research
Volume 21, Issue 3 , Pages 227-230 , July 1995

Retrospective study of vigabatrin and psychiatric behavioural disturbances

Received 18 January 1995 ,Revised 28 March 1995 ,Accepted 29 March 1995.

References 

  1. Sander JWAS, Hart Y. Vigabatrin and behaviour disturbances. Lancet. 1990;335:57
  2. Robinson MK, Richens A, Oxley R. Vigabatrin and behavioural disturbances. Lancet. 1990;336:504
  3. Dam M. Vigabatrin and behaviour disturbances. Lancet. 1990;335:605
  4. Johnston SJ. Vigabatrin and behaviour disturbances. Lancet. 1990;335:606
  5. Grant SM, Heel RC. Drug evaluation: Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in epilepsy and disorders of motor control. Drugs. 1991;41:889–926
  6. Schmidt D, Kramer G. The new anti-convulsant drugs: Implications for avoidance of adverse effects. Drug Safety. 1994;11:422–431
  7. Brodie MJ, McKee PJW. Vigabatrin and behaviour disturbances. Lancet. 1990;335:1279
  8. Marion Merrell Dow Ltd . Sabril Data Sheet. 1994;
  9. Remy C, Favel P, Tell G, Hardenberg J, Schechter PJ. Etude en double aveugle contre placebo en permutations croisees du vigabatrin dans I'epilepsie de I'adulte resistant a la therapeutique. Boll. Lega. Ital. Epil. 1986;54/55:241–243
  10. Loiseau P, Hardenberg JP, Pestre M, Guyot M, Schechter PJ, Tell GP. Double-blind placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy. Epilepsia. 1986;27:115–120
  11. Gram L, Klosterskov P, Dam M. Gamma-vinylGABA: A double-blind placebo-controlled trials in partial epilepsy. Ann. Neurol. 1985;17:262–266
  12. Rimmer EM, Richens A. A double-blind study of gamma-vinyl-GABA in patients with refractory epilepsy. Lancet. 1984;1:189–190
  13. Tartara A, Manni R, Galimberti CA, et al.  Vigabatrin in the treatment of epilepsy: A double-blind placebo-controlled study. Epilepsia. 1986;27:717–723
  14. Tassinari CA, Michelucci R, Ambrosetto G, Salvi F. Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy. Arch. Neurol. 1987;44:907–910
  15. Ring HA, Crellin R, Kirker S, Reynolds EH. Vigabatrin and depression. J. Neurol. Neurosurg. Psychiatry. 1993;56:925–928
  16. Aldenkamp AP, Vermeulen OG, Mulder JO, Overweg J, Van Parys JAP, Beun AM, et al. Gamma-vinyl GABA (vigabatrin) and mood disturbances. Epilepsia. 1994;35:999–1004
  17. Sander JWAS, Trevisol-Bittencourt PC, Hart YM, Shorvon SD. Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy. J. Neurol. Neurosurg. Psychiatry. 1990;53:1008–1010
  18. Sommerville KW, Sussman NM, Vaughan L. Vigabatrin and behaviour in patients with a pscyhiatric history (abstract). Neurology. 1994;44(suppl. 2):A204

PII: 0920-1211(95)00022-3

Epilepsy Research
Volume 21, Issue 3 , Pages 227-230 , July 1995

Article Tools